Please note: The information displayed on this page might be outdated.
HiFiBiO: Developer a single-cell analytics platform designed to mobilize the human immune system to combat cancer and autoimmune disorders. The company's drug offers ultra-high-throughput antibody selection, unprecedented single-cell resolution and integrates deep-rooted biological expertise with comprehensive profiling technologies, enabling doctors to identify therapeutic molecules for the treatment of cancer and autoimmune disorders.
Investors: Delian Capital; Hanne Capital; TIDG Capital; Kite Pharma; Legend Star; LYFE Capital; Sequoia Capital; Vi Ventures
Sector/industry:
Healthcare
Characteristics:
Based in...
North America
Disease Space
Autoimmune, Oncology
Listing
Private
Therapeutic Modalities
Antibodies
Website:
Profiles:
Address:
Cambridge, Ile-de-France 02139
United States

Company Participants at Solebury Trout Corporate Access Calls - May 11&12

  • Liang Schweizer, PhD, Co-Founder and CEO
  • Tim Miller, Director of Business Development and Alliance Management

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.